Genome- and epigenome-wide studies of plasma protein biomarkers for Alzheimer's disease implicate TBCA and TREM2 in disease risk. (2022)

First Author: Hillary RF
Attributed to:  Quantitative Traits in Health and Disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/dad2.12280

PubMed Identifier: 35475137

Publication URI: http://europepmc.org/abstract/MED/35475137

Type: Journal Article/Review

Volume: 14

Parent Publication: Alzheimer's & dementia (Amsterdam, Netherlands)

Issue: 1

ISSN: 2352-8729